Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
BEDFORD, Mass., Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod® Insulin Management System, today announced that Duane DeSisto, Chief Executive Officer, will participate in the 26th Annual JPMorgan Healthcare Conference. Mr. DeSisto is scheduled to present an overview of the Company at 1:30 p.m. Pacific Time on Tuesday, January 8, 2008 at The Westin St. Francis Hotel in San Francisco.
During the conference presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of the presentation during the event, please visit: http://investors.insulet.com. A replay of the webcast will be available for 90 days.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.
Stephanie Marks for Insulet Corporation
SOURCE Insulet Corporation